π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The main purpose of the study is to evaluate the safety and tolerability of...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2022-12-14
Trial ID
NCT05675449
Treatments Being Tested
The purpose of this clinical trial is to learn how the experimental medicin...
Status
Terminated
Location
Keck Hospital of USC
Start Date
2018-05-14
Trial ID
NCT03530683
This study will test the safety of TTI-622 in combination with daratumumab ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2021-10-28
Trial ID
NCT05139225
Treatments Being Tested
The purpose of this study is to learn about the effects of three study medi...
Status
Terminated
Location
Mary Bird Perkins Cancer Center
Start Date
2023-08-04
Trial ID
NCT05626322
Treatments Being Tested
This phase II trial tests the safety, side effects, and best dose of TTI-62...
Status
Active Not Recruiting
Location
University of Iowa
Start Date
2023-04-19
Trial ID
NCT05507541
Pegylated liposomal doxorubicin (PLD), a type of chemotherapy, is a standar...
Status
Terminated
Location
Sarcoma Oncology Research Center
Start Date
2022-08-01
Trial ID
NCT05261490
Treatments Being Tested
The purpose of this clinical trial is to learn about how safe and tolerable...
Status
Completed
Location
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Start Date
2022-11-02
Trial ID
NCT05567887
Treatments Being Tested
The purpose of this study is to learn about the safety and what the body do...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2023-06-28
Trial ID
NCT05896774
Treatments Being Tested